Under the banner of anti-discrimination, recently established advocacy group Do No Harm (DNH) seeks to eliminate diversity initiatives in healthcare. DNH believes that diversity, equity, and inclusion (DEI) practices are plain discrimination against certain demographics of patients, medical students, and healthcare workers, which ultimately harms patient health outcomes. This belief contradicts current healthcare and public health goals of utilizing diversity-conscious practices to promote equity and mitigate disparities in healthcare. Legitimization of DNH’s mission would further politicize equity in medicine and frustrate preexisting efforts to eliminate health disparities.
Background
Retired physician Stanley Goldfarb founded DNH in 2022 to fight for “the elimination of all discrimination in healthcare.” As a national association comprised of like-minded patients, medical professionals, and policymakers, DNH primarily utilizes media, lobbying, and litigation to target pediatric gender-affirming care and DEI practices.
DNH pursues litigation over initiatives like diversity fellowship scholarships, DEI hiring practices, and clinical care practices specialized to meet the needs of racial and ethnic minorities. DNH believes that tailoring healthcare opportunities to racial minorities, women, and other minority groups discriminates against all other “non-minority” groups. DNH grounds its arguments in various combined readings of Title VI of the Civil Rights Act of 1964, Section 1557 of the Affordable Care Act (ACA), and the Equal Protection Clause of the Fourteenth Amendment. These federal provisions prohibit discrimination on the basis of race, color, ethnicity, and sex, and typically resolve cases involving discrimination against a racial, religious, or gender minority. Spurred by changes implemented by the U.S. Supreme Court, DNH wants to use these federal provisions to protect non-minority groups from discrimination.
In the 2023 decision from SFFA v. Harvard, SCOTUS said that “[e]liminating racial discrimination means eliminating all of it”, reinforcing a statement from an 1886 case that the Equal Protection Clause applies “without regard to any difference of race, of color, or of nationality”. The Court held that colleges and universities are now prohibited from considering race as a factor in admissions. After this decision, groups like DNH began filing claims with intent to expand the scope of SFFA v. Harvard to non-university parties, including medical schools and healthcare workplaces.
Like other industries, healthcare evolved over time and gradually implemented diversity-conscious practices to address identified disparities. Medical schools and healthcare employers established policies and opportunities for traditionally underrepresented groups to enter the medical field. Proponents of health equity believed DEI would lead to more accurate, bias-checked medical opinions and treatment decisions, and that a diverse range of physicians caring for a diverse patient population would improve patients’ overall experience and trust in the healthcare system.
DNH discredits diversity initiatives in its own compiled report, which discusses a lack of hard evidence that diversity-conscious practices improve clinical outcomes and “debunks” the methodology of select pro-DEI research. Advocates of diversity initiatives defend the practice by pointing to records of positive subjective patient experiences and a social need to remedy historical inequity in the profession. DNH opposes those exact ideas: first, that diversity in the healthcare workforce results in improved patient health outcomes; and second, that medicine is a practice where equal opportunity matters more than, or as much as, training “the best and the brightest”.
Recent Action by Do No Harm
In March 2024, House Representative Greg Murphy introduced the EDUCATE Act, which proposes a ban on federal funding for medical schools that “force students or faculty to adopt specific beliefs, discriminate based on race or ethnicity, or have diversity, equity, and inclusion (DEI) offices or any functional equivalent.” DNH founder Dr. Goldfarb supported the Act, saying, “If we fail to stop [DEI ideology in medical schools], we risk a generation of physicians ill-equipped to meet the needs of their patients.” Endorsement of the EDUCATE Act reflects DNH’s fear that medical schools are prioritizing diversity and equity over quality medical training, to the detriment of patient health outcomes. The status of the Act has not changed since its referral to the Committee on Health, Education, Labor, and Pensions.
In June 2024, DNH filed a complaint in federal court, challenging a policy of the American Association of University Women (AAUW) that limited eligibility for its fellowship program to women applicants of ethnic minority groups. The court dismissed the case after AAUW agreed to drop race from criteria for consideration of the fellowship. In its August 2024 statement, AAUW acknowledged that “recent Supreme Court decisions have changed how we must fight for equity”, likely referring to SFFA v. Harvard.
In August 2024, DNH filed a complaint with the U.S. Department of Health and Human Services, Office for Civil Rights (OCR), urging an investigation into the Cleveland Clinic. Since 2019, Cleveland Clinic’s Minority Stroke Program“tailor[ed] treatment and prevention services to Black and Latino patients, including medical referrals and post-stroke care” to address the disparity that “Black men and women are at least two times as likely as white Americans to die from strokes.” DNH alleged that the minority-focused programming violates non-discrimination mandates under Title VI and Section 1557 of the ACA. In September 2024, OCR announced it would investigate the complaint.
Discussion
DNH’s litigation efforts against pro-DEI organizations indicate that any program with DEI initiatives is susceptible to equal protection challenges and discrimination claims. Data, studies, and research in support of one side or the other are frequently met with scrutiny by the opposing side. For example, DNH itself lauded research that “debunked” an influential study on racial concordance and newborn mortality that was often cited by scholars and administrators to justify DEI-conscious admissions at medical schools. The public is adversely affected by apparent discord among medical scholars and health policymakers, with one study attributing a lack of trust in public health agencies to perceptions of political influence within the agency, which risks undermining public health efforts. Further politicization of equity and other healthcare goals frustrates actual progress towards improving health for all.
Updates are slow in this area of health, law, and equity. The ongoing focus and frequency of DNH activity should put organizations on notice to carefully consider existing DEI practices and prepare to either defend or drop diversity-conscious language from any program goals and requirements. Choosing to defend risks the possibility of a court applying the SFFA v. Harvard prohibition on race considerations to this specific healthcare context, or even extending the reach of SFFA v. Harvard to DEI-centered fellowships, research programs, and pipeline programs in every industry, not just healthcare. No court has definitively ruled on the merits of a claim alleging discriminatory diversity-conscious healthcare and medical school programming. Like the AAUW case described above, most cases are dismissed for procedural reasons without judicial comment on discrimination and DEI. However, every lawsuit DNH files against pro-DEI organizations is a step in that direction.
Here in Illinois, DNH has not filed any lawsuits alleging discriminatory practices by healthcare corporations and medical schools. In August 2022, DNH did file an administrative complaint with the Department of Education, Office of Civil Rights (Chicago OCR) against Loyola University Chicago Stritch School of Medicine (Loyola), calling out an internship program that “intended to encourage medical students from racial and ethnic groups that are underrepresented in medicine to consider pursuing a career in academic surgery” in violation of Title VI. Eligibility requirements for the program included the criterion of “African American/Black, Hispanic/Latinx, American Indian/Alaska Native, Native Hawaiian/Pacific Islander”. Chicago OCR dropped its investigation in February 2023 because Loyola removed the contested criterion from its eligibility requirements. Now, the program “invites outstanding students who self-identify as underrepresented in Surgery from a social, economic, or educational perspective” to apply.
In October 2024, DNH Senior Fellow Mark Perry submitted a complaint to Chicago OCR on behalf of DNH against Midwestern University over its dental school scholarship program, which is open to students from “underrepresented minority groups”. According to Perry, the program violates Title VI and is “not legal”. Other than a November 2024 news clip on the DNH site, no further updates are currently available on this matter. Perhaps like Loyola and the AAUW, Midwestern University will eventually rephrase or omit the challenged language from its program requirements.
Other than scholarship programs, minority-focused clinical care and research programs are prime targets for DNH attention. The University of Illinois at Chicago College of Medicine currently runs the Institute for Minority Health Research, which aims to promote research and other interventions to “improve the health of vulnerable minority populations living locally, nationally, and internationally.” DNH could attack the Institute for its apparent catering to “minority populations” over non-minorities, similar to its argument in the Cleveland Clinic investigation.
DNH continues to submit complaints against organizations with DEI practices, condemning claims that minority representation in healthcare contributes to improved patient health outcomes. By pursuing its goal of ending discrimination against non-minorities in healthcare, DNH is polarizing what could be a collaborative discussion on the optimal ways to improve health. “Equity” is now a politicized term rather than a fundamental principle of health and medicine. If any judicial or legislative action legitimizes the goals of DNH and specifically applies SFFA v. Harvard and equal protection to this healthcare context, DEI healthcare and medical programs risk total invalidation —something to keep an eye on in the upcoming years.